Clinical Trials Browser

Hyperthermia, Anus Neoplasms, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fever, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Neuroendocrine Tumors

NCT06128460 2023-11-30

Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer.

Phase 2 Not yet recruiting

24 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06149767 2023-11-29

Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

Phase 2 Not yet recruiting

26 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT06039891 2023-09-15

Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical Cancer

Phase 2 Not yet recruiting

55 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05805358 2023-08-30

DNPSPIO

Phase 2 Not yet recruiting

90 enrolled

Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms

NCT05824494 2023-05-06

Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors

Phase 2 Not yet recruiting

58 enrolled

Gynecologic

Uterine Cervical Neoplasms

NCT05799469 2023-04-05

Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer

Phase 2 Not yet recruiting

36 enrolled

Gynecologic

Uterine Cervical Neoplasms

Clinical Trials

Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer

A Single-arm, Open-label, Multicenter, Phase Ib/II Clinical Trial of CVL237 Tablets in Combination With Serplulimab Injection for the Treatment of Advanced Solid Tumors With PTEN Loss or Low Expression

A Single-arm, Multicenter Clinical Study of Becotatug Vedotin Combined With Zimberelimab in the Treatment of Recurrent and Metastatic Cervical Cancer, Vulvar Cancer and Vaginal Cancer

GCCC 2578 Randomized Photon vs Proton RT for Newly Diagnosed Gynecologic Primaries

RIFT-SSA

Pembrolizumab and Lenvatinib in Patients With High Risk Locally Advanced Cervix Cancer

A Phase II Study of Utidelone With Toripalimab in Advanced Cervical Cancer

A Phase II Study of Neoadjuvant Sacituzumab Tirumotecan in Combination With Iparomlimab and Tuvonralimab in Locally Advanced Cervical Cancer

HypoRTCx-UG

SKB264 Plus QL1706 in Recurrent or Metastatic Cervical Cancer

Neoadjuvant Ivonescimab Plus Chemotherapy Followed by Concurrent Chemoradiotherapy in High-Risk Locally Advanced Cervical Cancer

Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV

Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer

The Efficacy and Safety RC48 Plus QL1706 in Second-Line Treatment of HER2-Expressing Recurrent CC

QL1706 in Patients With Recurrent and Metastatic Cervical Cancer Resistant to Prior PD-1/PD-L1 Antibody Therapy

a Single Arm, Phase II Multicenter Clinical Trial to Evaluate the Efficacy and Safety of the Combination Therapy of Iparomlimab and Tuvonralima b and Chemotherapy ± Bevacizumab Induction Therapy Followed by Concurrent Chemoradiotherapy in Patients With Advanced Cervical Cancer .

Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical Cancer

QL1706

BROTHER

Herombopag for the Prevention of Radio-chemotherapy Induced Thrombocytopenia in Cervical Cancer

A Multicenter, Open-label Phase IIa Clinical Study to Evaluate the Efficacy and Safety of B1962 Injection in the Treatment of Advanced Malignant Solid Tumors

Cnidium Monnieri Detoxification Formula for Persistent High-risk Human Papillomavirus Infection of Cervix.

HPV9vxFSW

CVL009-C2001

Myeloprotection With Trilaciclib in Pan-cancer Population

HETERERO

Adjuvant Chemoradiotherapy Followed by Zimberelimab for Locally Advanced Cervical Cancer.

Clinical Study of Adebrelimab Combined With Concurrent Chemoradiotherapy in Cervical Cancer

Nimotuzumab Plus Tislelizumab for Recurrent and Metastatic Cervical Cancer

DNPSPIO

Cadonilimab Plus Nab -Paclitaxel for Patients With Recurrent, or Metastatic Cervical Cancer Resistant to Immune Checkpoint Inhibitors

Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer